The Impact of Inclusion in a Quality Indicators Program on Anticoagulant Treatment in Atrial Fibrillation

Abstract

Get full access to this article

View all access options for this article.

References

January

Wann

Alpert

. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014;64:e1-e76.

Brandes

Overgaard

Plauborg

. Guideline adherence of antithrombotic treatment initiated by general practitioners in patients with nonvalvlar atrial fibrillation: a Danish survey. Clin Cardiol. 2013;36:427-432.

Meinertz

Kirch

Rosin

. Management of atrial fibrillation by primary care physicians in Germany: baseline results of the ATRIUM registry. Clin Res Cardiol. 2011;100:897-905.

Cowan

Healicon

Robson

. The use of anticoagulants in the management of atrial fibrillation among general practices in England. Heart. 2013;99:1166-1172.

Volterrani

Iellamo

Rosano

; SICOA (Società Italiana Cardiologia Ospedalità Accreditata) Investigators. Anticoagulation in “real world” patients with atrial fibrillation in Italy: results from the ISPAF (Indagine Sicoa Paziente Con Fibrillazione Atriale) survey study. Int J Cardiol. 2013;168:4729-4733.